Agent for inhibiting a decrease in bone mass in renal osteodystrophy

摘要

A pharmaceutical composition comprising 24, 25-dihydroxycholecalciferol is useful for the remedy or prophylaxis of disorders associated with renal osteodystrophy. The active compound, 24, 25-(OH)₂-D₃, alone unexpectedly not only improves bone quality but also prohibits bone mass decreases in renal osteodystrophy.